Theresa Bowers joins Zionexa as US Sales Manager

Zionexa is pleased to welcome Theresa Bowers to the Zionexa team as US Sales Manager. Her mission will be to lead the US sales team.


Zionexa is an international company developing and commercializing in-vivo biomarkers for targeted therapies in oncology aimed at improving patients’ pathway and quality of life. Zionexa is actively working on developing its pipeline of molecules in the US market and Theresa will support this thanks to her expertise in the sales field for molecular imaging solutions, in order for Zionexa to commercialize new biomarkers.

Theresa Bowers joins Zionexa’s New York office with a solid experience in sales. Most recently she was with Sofie where she was Regional Sales Director. Her experience also includes IBA Molecular and Integral PET. She has a Bachelor of Science in Nuclear Medicine from the Rochester Institute of Technology.

“This is a great time to join Zionexa, with multiple key projects and a molecule currently under review by the FDA. I am excited to be part of the team and honored to work for a such promising company in the molecular imaging industry.”, Theresa Bowers said.

Commenting on Theresa’s new assignment at Zionexa, Peter Webner, Zionexa U.S. CEO: “We are pleased to welcome Theresa in the team. With her rich experience in the molecular imaging sales field, there is no doubt that she will be a key member for our US development strategy, supporting our activities to provide clinicians access to our innovative molecules for their patients.”


Please join us in welcoming Theresa to the Zionexa team.

Fludarabine labelled with Fluor 18: a new radiotracer for onco-hematology